Accueil/Actions/OCS

OCS

USD

Oculis Holding AG Ordinary shares

$19.270-0.130 (-0.670%)

Prix en Temps Réel

Healthcare

Biotechnologie

Suisse

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$19.400

Haut

$19.400

Bas

$19.080

Volume

0.12M

Fondamentaux de l'Entreprise

Capitalisation Boursière

1.1B

Industrie

Biotechnologie

Pays

Switzerland

Statistiques de Trading

Volume Moyen

0.05M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $14Actuel $19.270Haut $23.08

Actualités Connexes

5 nov. 2025 · 09:00

GlobeNewswire

Oculis to Participate in Upcoming November Investor Conferences

ZUG, Switzerland, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (NASDAQ:OCS) ("Oculis"), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in

Oculis to Participate in Upcoming November Investor Conferences

30 oct. 2025 · 08:30

GlobeNewswire

Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development

ZUG, Switzerland, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (NASDAQ:OCS, XICE: OCS)) ("Oculis" or the "Company"), a global biopharmaceutical company focused on breakthrough innovations to address significant